MedPath

Role of innate immunity and fibrinolysis in the development of post thrombotic syndrome: a case-control study

Recruiting
Conditions
post phlebitic syndrome
10064477
10014523
Registration Number
NL-OMON35458
Lead Sponsor
Medisch Universitair Ziekenhuis Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

All adult and consenting.;Cases:
- Having had a DVT 2-10 years ago
- PTS according to the Villalta scale: Villalta score >=5 on two or more consecutive visits that were at least 3 months apart or venous ulceration;Controls:
- Having had a DVT 2-10 years ago
- No PTS;Healthy controls:
- Never had a DVT during their life
- No venous insufficiency caused by other factors (CEAP<3)

Exclusion Criteria

- Preexistent venous insufficiency (skin signs C3-C6 on CEAP score or requiring ECS therapy)

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary outcome will be the difference in levels of plasma concentrations<br /><br>of markers in relation to the outcome PTS between participants with PTS and<br /><br>participants without PTS</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- Dose-dependent relation between the level of markers and severity of PTS.<br /><br>- Plasma concentration of markers in healthy controls that never had a DVT,<br /><br>compared to patients that have had a DVT.</p><br>
© Copyright 2025. All Rights Reserved by MedPath